Gladiator Therapeutics, LLC

Gladiator Therapeutics, LLC develops and commercializes non-powered far infrared (FIR) therapeutic devices based on patented SemiCera® ceramic emitter technology. The company specializes in wound healing, post-operative recovery, and pain/inflammation management through strategically placed ceramic emitters that activate cellular regeneration and accelerate healing. Primary applications include surgical post-operative wound healing, chronic wound management, and emerging evidence for Parkinson's disease symptom management. The company's technology platform leverages quantum physics principles and ceramic-based far infrared emission to stimulate stem cell proliferation without requiring powered electronics. Research published in peer-reviewed journals (Life Cell Biology and Tissue Engineering Journal, MDPI) documents accelerated wound healing outcomes from independent researchers at the University of Central Florida College of Medicine. Products are marketed to both clinical and consumer (home therapy) segments, with endorsements from NCAA athletes and clinical case studies. The company positions itself as offering a non-invasive, cost-reducing alternative to conventional wound care and pain management protocols.